• 1. An atmosphere and light tuned highly diastereoselective synthesis of cyclobuta/penta[b]indoles from aniline-tethered alkylidenecyclopropanes with alkynes?
  Bo Cao,Yin Wei Chem. Commun., 2018,54, 2870-2873
• 2. An integrated microfluidic platform for sensitive and rapid detection of biological toxins?
  Robert J. Meagher,Anson V. Hatch,Ronald F. Renzi,Anup K. Singh Lab Chip, 2008,8, 2046-2053
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An alumina stabilized graphene oxide wrapped SnO2 hollow sphere LIB anode with improved lithium storage?
  Xiang Liu,Qian Sun,A. B. Djuri?i?,Maohai Xie,Baohu Dai,Jinyao Tang,Charles Surya,Changzhong Liao,Kaimin Shih RSC Adv., 2015,5, 100783-100789
• 5. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296

Introduction to 3-Hydrazino-4-methylbenzoic Acid (CAS No. 61100-70-7)

3-Hydrazino-4-methylbenzoic acid is a specialized organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its unique structural properties and potential applications. This compound, identified by the Chemical Abstracts Service Number (CAS No.) 61100-70-7, belongs to the class of hydrazinoaromatic acids, which are known for their versatility in medicinal chemistry. The presence of both a hydrazino group and a carboxylic acid moiety makes it a valuable intermediate in the synthesis of various bioactive molecules.

The structural framework of 3-hydrazino-4-methylbenzoic acid consists of a benzoic acid core substituted with a methyl group at the 4-position and a hydrazino group at the 3-position. This arrangement imparts distinct chemical reactivity, making it a useful building block for further functionalization. The compound exhibits moderate solubility in polar organic solvents, which facilitates its use in synthetic protocols. Its molecular formula, C₈H₁₀N₂O₂, reflects its composition and highlights its nitrogen-rich nature, which is often exploited in drug design for interactions with biological targets.

In recent years, 3-hydrazino-4-methylbenzoic acid has been explored in several cutting-edge research areas within pharmaceutical chemistry. One notable application lies in the development of novel antimicrobial agents. The hydrazino group can participate in coordination with metal ions, leading to the formation of metal complexes that exhibit enhanced antimicrobial properties. Studies have demonstrated that complexes derived from this compound show promising activity against resistant bacterial strains, making them a subject of intense investigation for potential therapeutic use.

Furthermore, the carboxylic acid functionality in 3-hydrazino-4-methylbenzoic acid allows for further derivatization into esters or amides, expanding its utility as a synthetic precursor. Researchers have leveraged these properties to develop new scaffolds for kinase inhibitors, which are critical in treating cancers and inflammatory diseases. The benzoic acid core itself is well-documented for its role in various pharmacophores, contributing to the compound's appeal as a starting material for drug discovery programs.

The hydrazino group is particularly interesting from a chemical biology perspective. It can undergo reactions such as cycloadditions with alkynes or dienes, enabling the construction of complex cyclic structures. These transformations have been utilized to create novel heterocycles that mimic natural products and exhibit unique biological activities. For instance, derivatives of 3-hydrazino-4-methylbenzoic acid have shown potential as inhibitors of enzymes involved in metabolic pathways relevant to neurodegenerative diseases.

Recent advances in computational chemistry have also highlighted the significance of 3-hydrazino-4-methylbenzoic acid as a scaffold for virtual screening campaigns. Its molecular characteristics make it an ideal candidate for docking studies aimed at identifying new drug candidates. High-throughput virtual screening has identified several promising hits derived from this compound that interact with target proteins implicated in infectious diseases and cancer.

The synthesis of 3-hydrazino-4-methylbenzoic acid itself presents an intriguing challenge due to the need to introduce both functional groups selectively. Traditional synthetic routes often involve multi-step processes starting from commercially available aromatic precursors. However, recent methodologies have focused on more efficient one-pot reactions that minimize byproducts and improve yields. These advancements have made the compound more accessible for researchers worldwide, fostering further exploration of its applications.

In conclusion, 3-hydrazino-4-methylbenzoic acid (CAS No. 61100-70-7) represents a versatile and valuable intermediate in modern pharmaceutical research. Its unique structural features and reactivity profile have positioned it as a key player in drug discovery efforts targeting various diseases. As research continues to uncover new synthetic strategies and biological applications, this compound is poised to remain at the forefront of medicinal chemistry innovation.

• 38235-71-1(3-Hydrazinobenzoic acid)
• 5326-27-2(2-hydrazinylbenzoic acid)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)